Related Experiment Videos

Correlation of cerebrospinal fluid endotoxinlike activity with clinical and laboratory variables in gram-negative

Insights

The Limulus amebocyte lysate (LAL) assay is a sensitive and specific screening tool for diagnosing gram-negative bacterial meningitis. This cost-effective test offers prognostic value, aiding in patient management and predicting outcomes.

Area of Science:

  • Microbiology
  • Clinical Diagnostics
  • Biochemistry

Background:

  • Gram-negative bacterial meningitis diagnosis relies on sensitive and specific methods.
  • Limulus amebocyte lysate (LAL) gelation assay shows promise for detecting endotoxinlike activity in cerebrospinal fluid (CSF).

Purpose of the Study:

  • To evaluate the diagnostic accuracy and prognostic value of the LAL microassay for gram-negative bacterial meningitis.

Main Methods:

  • Prospective screening of 1,503 CSF specimens using a Limulus amebocyte lysate microassay.
  • Confirmatory retesting of positive specimens and comparison with bacterial culture results.
  • Analysis of correlations between endotoxinlike activity levels and clinical parameters.

Main Results:

  • The LAL assay demonstrated high sensitivity (97.3%) and specificity (99.5%) for detecting gram-negative bacterial meningitis.
  • Confirmed positive tests showed a positive predictive value of 97.3% and a negative predictive value of 99.9%.
  • Higher endotoxinlike activity levels correlated with shorter illness duration, elevated CSF protein, seizures, neutropenia, and mortality.

Conclusions:

  • The Limulus amebocyte lysate microslide gelation test is a sensitive, specific, simple, and inexpensive screening test for gram-negative bacterial meningitis.
  • The LAL assay possesses prognostic value, correlating with disease severity and patient outcomes.

Related Concept Videos